A newly published study in the Lancet suggested that a first-line treatment regimen including Zometa® (zoledronic acid) significantly improved overall survival (OS) and progression-free survival (PFS) in newly diagnosed multiple myeloma patients compared with a regimen that included oral...
What are your thoughts on the World War III Prophecy. They say it will be from Late December 2010- 2014, but because of rising Nuclear Power it will continue to 2059! What the?
Merck reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral...
Which should I take if I'm taking Calc II this quarter?
Introduction to Differential Equations: Introductory course in ordinary differential equations. Includes first- and second-order equations and Laplace transform.
Calculus III: Third quarter in calculus sequence. Introduction to Taylor...
My dad has a '66 GTO with a '69 RAM AIR III, including exhaust manifolds and complete intake.
The engine has around 20,XXX miles on it.
He would like to know the value of the engine, because he is going to drop the original engine back in.
Teams Question..*DETAILS INSIDE*? *A little while ago.. I asked two questions listing a bunch of nicknames had by professional wrestlers.. and your task was to give me the wrestler who had that nickname.. so here is part three of that little game.. sorry if I accidentally repeat a nickname that...
Bayer Schering Pharma AG, Germany, announced that data from Phase I and II studies evaluating two of the company's late-stage pipeline cancer treatments AlpharadinTM (radium-223 chloride) and regorafenib (BAY 73-4506) will be presented at the 35th European Society for Medical Oncology (ESMO)...
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the Phase III TAMARIS trial evaluating the investigational angiogenic therapy NV1FGF (riferminogen pecaplasmid) did not meet its primary endpoint. The primary endpoint was to demonstrate the superiority of NV1FGF vs. placebo in the...